JPRN-UMIN000003993招募中未知
Feasibility study of carboplatin plus TS-1 combination chemotherapy for completely resected non-small cell lung cancer (ALCSG-1001) - Feasibility study of carboplatin plus TS-1 combination chemotherapy for completely resected non-small cell lung cancer (ALCSG-1001)
Respiratory Center, Asahikawa Medical University Hospital0 个研究点目标入组 50 人开始时间: 2010年8月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients unable to get treatment of CBDCA or TS-1. 2. Sever allergy. 3. Interstitial pneumonia. 4. Active concomitant neoplasia. 5. uncontrolled heart diseases. 6. Pregnant, lactating women. 7. Sever complications. 8. Inappropriate patients judged by physicians.
研究者
相似试验
招募中
2 期
Phase I/II trial of carboplatin, TS-1, and concurrent radiation therapy in patients with unresectable locally advanced non-small cell lung cancernresectable locally advanced non-small cell lung cancerJPRN-UMIN000011663Dokkyo Medical University40
已完成
不适用
Phase I/II trial of carboplatin, TS-1, and concurrent radiation therapy in elderly patients with locally advanced non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000005794ational Cancer Center Hospital East40
已完成
2 期
Carboplatin and TS-1 combination chemotherapy in cancer of unknown primary site : a phase II multicenter trialCancer of unknown primary siteJPRN-UMIN000023961ational Cancer Center Hospital35
未知
不适用
Phase I–II study of TS-1 and Carboplatin in advanced Non Small Lung Cancernon small cell lung cancerJPRN-C000000054Department of Medical Oncology, Kinki University School of Medicine25
已完成
不适用
Study of carboplatin based combination chemotherapy for good prognosis metastatic malignant teratomaCancerTesticular cancerISRCTN69711558Medical Research Council (MRC) (UK)450